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Metabolism of 2-Aminofluorene by Human
Polymorphonuclear Leukocytes: More
Evidence for the Association between
Inflammation and Cancer
byVicki J. Isola,' Tahnee C. Hartman,' Scott J.
Trumble,' Melanie C. Ruzek,' and James M. Gentile'
Recent investigations have demonstrated the ability of leukocytes to metabolize promutagens or procar-
cinogens into their genotoxic forms. As apossible explanation forthe association between inflammation and
cancer, we and others have hypothesized that local accumulations of leukocytes could take up nearby
promutagens, metabolize them, and release genotoxic agents that may cause damage in the surrounding
tissue. Using amodified, two-step preincubation protocol with Salmonella, we havetested this hypothesis.We
have shown that total human peripheral blood leukocytes, cultured in the presence of2-aminofluorene for18
hr, can metabolize 2-aminofluorene into agents mutagenic toSalmonella typhimurium strain TA98. Further-
more, experiments in which polymorphonuclear leukocytes were separated from mononuclear leukocytes
demonstrated that the PMNs metabolized 2-aminofluorene to a much greater extent than the MNs.
Introduction
We are interested in the association between parasite
infestation and cancer. It is well established that a high
correlation existsbetweenthe occurrenceofsomeparasite
diseases and enhanced incidence of neoplasia (1,2). One
hypothesis to explain this relationshipis an alteredmetab-
olismintheparasitized host,whichrendersthathost more
susceptible to chemically induced carcinogenesis. Pre-
viously, we studied the metabolic potential ofS9 prepara-
tions from the livers of Fasciola hepatica infected and
noninfectedmiceandfoundthatS9fromtheinfectedlivers
had a greater ability to activate the promutagen aflatoxin
B1 into a mutagen detectable by the Ames assay than S9
from noninfected livers (3).
In addition to the infected organ(s), parasitized hosts
differfromtheirnoninfectedcounterpartsbythe presence
of a chronic inflammatory state. Thus, the inflammatory
cells, or leukocytes, could also contribute to the altered
metabolic capability of an infected host. We and others
(4,5) have hypothesized that local accumulations ofleuko-
cytes during inflammation could take up nearby pro-
mutagens, metabolize them, and release genotoxic agents
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that may cause damage in the surrounding tissue. To
study this possibility further, we wished to develop a
systemwherebywe could testthe overall abilityofhuman
leukocytes to activate a wide range of promutagens and
release agents that could cause damage in a nearby cell.
Many investigators have used the generation ofnucleic
acid binding species as an indicator of metabolism of a
xenobiotic by leukocytes (4,6-12), but only a few have
analyzed for the ability of metabolites to cause genetic
damage in cells other than the leukocytes themselves
(4,5,13). In addition, these studies have only investigated
xenobioticmetabolisminleukocytes stimulatedtoundergo
respiratory burstby a tumor promoter. We are interested
in the inherent ability of "resting" or nonstimulated
human leukocytes to metabolize the promutagen 2-ami-
nofluorene (2AF). Ithas previouslybeen shown that stim-
ulated human and guinea pig leukocytes and HL-60 cells
can metabolize 2AF into nucleic acid binding species
(6,7,12). In addition, purified leukocyte peroxidase
(myeloperoxidase) can metabolize 2AF into nucleic acid
binding species (7), and other peroxidaselike enzymes,
such as prostaglandin endoperoxide synthetase, can
metabolize 2AF into a Salmonella mutagen (14). Using a
modified, two-step preincubation protocol with whole and
separated peripheral blood leukocytes, we demonstrate in
thispaperthatrestinghumanleukocytes canalsometabo-
lize 2AF into a Salmonella mutagen.ISOLA ET AL.
Materials and Methods
Chemicals
RPMI 1640, fetal calf serum, glutamine, and Mono-poly
Resolving Media were obtained from Flow Laboratories
(McLean, VA). 2-Aminofluorene was purchased from
Aldrich (Milwaukee, WI). All other chemicals were obtained
from Sigma Chemical (St. Louis, MO), and the micro-
biological media were obtained from Difco (Detroit, MI).
Bacterial Tester Strains
Salmonella typhimurium strain TA98 wasprovidedby
B. N. Ames, Berkeley, CA, and maintained as a frozen
stock at -80°C as recommendedbyMaron andAmes (15).
Confirmation of strain identity was made using the
methods of Zeiger et al. (16). The range of spontaneous
mutant colonies per plate for this strain in our laboratory
was 20-60.
Isolation and Culture ofHuman Leukocytes
Heparinized human venousblood obtained fromhealthy
donors was overlayed onto 6% dextran (molecular weight
100,000-200,000)at a3:1 ratio(blood:dextran) andallowed
to sit for 1 hr at room temperature. The toplayer, contain-
ing the leukocytes, was removed and centrifuged at 330g
for 10 min. The pellet was treated once with lysing buffer
(0.15M NH4Cl, 0.1 M This base, pH 7.2) to lyse any
remainingerythrocytes. Thepelletwaswashedtwicewith
RPMI 1640, resuspended in complete media (RPMI 1640,
10% FCS, 1% glutamine), and seeded at 3-4 million cells/
mL in a total volume of 4 mL complete media in 25 cm2
tissue culture flasks. In some experiments, leukocytes
were separated directly from blood on Mono-poly Resolv-
ing Media, according to the manufacturer's instructions.
Themononuclearfractionandpolymorphonuclearfraction
were individually treated with lysingbuffer, washed, then
cultured in complete media as described above, atvarying
cell densities. Cell densities were determined bymixing an
aliquot of culture with trypan blue and counting under a
hemacytometer.
Preincubation Assay with Salmonella
Step 1. Appropriate dilutions of 2AF dissolved in
dimethyl sulfoxide were added to the culture flasks in
25-p.L aliquots resulting in final concentrations of 0-375
RM 2AF. Control flasks contained 2AF but no leukocytes.
The culture flasks were then incubated vertically with
loose caps at 37°C in a candle jar for 18 hr. Preliminary
experiments showed theleukocytes remainedviablein the
presence of up to 375 puM 2AF for the duration of the
preincubation period. The 18-hr incubation period was
chosenbased ontheresults ofGuptaetal. (8),whofound a
maximum amount of DNA adducts in lymphocytes incu-
bated with 2AF for 18 hr. Our own preliminary data (not
shown) also demonstrated the greatest amount of muta-
genic metabolites after incubating 2AF with leukocytes
for 18 hr.
Step 2. After 18 hr, culture supernatants were obtained
bycentrifugation and transferred to scintillationvials. We
added 0.2 mL ofan overnight broth culture ofSalmonella
typhimurium strain TA98 per milliliter of supernatant,
and the vials were placed in a shakingwaterbath for 3 hr.
Atypicalincubationvolumewas2.4mL.Wethenadded0.6
mL ofthismixtureto2mL oftopagarcontaining0.05mM
histidine-biotin. The top agarwas overlayed onto plates of
Vogel-Bonner medium E, and plates were incubated for
48-72 hr at 37°C. The visible colonies (revertants) that
formed were counted. Background plates contained 0.5
mL of complete media and 0.1 mL of overnight broth
culture to correct for the added amount ofhistidine.
Each group ofexperiments was repeated a minimum of
three times, and three plates were averaged for each data
point. Because of the day-to-day variation of the white
blood cells andvolunteer-to-volunteervariation, individual
experimental data could not be pooled. However, all ofthe
trends remained the same in each experiment, and the
specific results presented are representative of all the
results obtained. This dailyvariationinmetabolic capacity
of cells from the same person as well as variation from
person to person has been noted by other authors (8,12).
Results
To determine if human leukocytes could activate 2AF
into an agent mutagenic to Salmonella typhimurium
TA98 and release that agent into the surrounding media,
leukocytes were incubatedwith increasingconcentrations
of2AF for 18 hr, and the supernatants were examined for
mutagenic activity in a typical Ames preincubation assay
(Fig. 1). Underthese conditions, theresulting supernatant
was mutagenic to the bacteria in a dose-dependent man-
ner. Supernatantfrom cultures containingleukocytes and
increasing concentrations of 2AF up to 375 FLM caused
increasing numbers of revertants in the Salmonella.
Supernatants from cultures of human leukocytes alone,
2AF alone, or 2AF incubated in the presence of boiled
human leukocytes (data not shown) failed to induce muta-
tions in the bacteria.
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FIGURE 1. Activation of 2-aminofluorene incubated in the presence
(0-0) and absence (0-0) ofhuman leukocytes.
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TMETABOLISM OF 2AF BY HUMAN LEUKOCYTES
Because total peripheral blood leukocyte cultures con-
tain two major groups of leukocytes, the polymorphonu-
clear leukocytes (PMNs) and the mononuclear leukocytes
(MNs),wewereinterested inwhich groupwas responsible
for the activation of 2AF. Therefore, we separated the
leukocytes into mononuclear and polymorphonuclear frac-
tions and tested their ability to activate 2AF individually
compared to collectively (Fig. 2). PMNs did the most
activation, similar to that performed by both PMNs and
MNs together, whereas the MN fraction alone only
slightly activated the 2AF.
We tested the effect of cell density on the activation of
2AF (Figs. 3, 4). Increasing concentrations of PMNs in
the culture flasks from 0 to 1.2 million cells/mL produced
an increasingly mutagenic supernatant. A second experi-
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FIGURE 2. Activation of 2-aminofluorene in cultui-es containing no
leukocytes (0-0), mononuclear leukocytes only (A-A), poly-
morphonuclear leukocytes only (A-A), and both polymor-phonuclear-
leukocytes and mononuclea- leukocytes ( -0).
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FIGtURE 3. Activation of 2-aminofluorene by incr-easing concentrations of
mononuclear leukocytes (MNs) (A -A) and polymiorphonuclear leuko-
cytes (PMNs) (A
- A). MNs were incubated at 0.11, 0.24, 0.78,1.23,1.52,
and 2.24 million cells/mL, and PMNs were incubated at 0.09, 0.16, 0.31,
0.79, 0.98, and 1.21 million cells/mL with 250 p.M 2-aminofluorene.
mentusingPMN concentrationsfrom0 to4.7millioncells/
mL also showed increasing activation up to a density of
between 1 and 2 million cells/mL, with the amount of
activation leveling off beyond 2 million cells/mL. In both
experiments, MNs showed only a slight activation of2AF.
Discussion
Human leukocytes metabolize xenobiotics into agents
thatbind nucleic acid and cause genetic damage invarious
cell types. For example, leukocytes have been shown to
activate trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene
(BaP-7,8-diol) into agents that bind DNA (4,11), cause
mutations in Salmonella (4), and induce sister chromatid
exchanges inV79 cells (13). In addition, human leukocytes
have been shown to activate 2AF into agents that bind to
leukocyte DNA (7,12). In this paper we show that human
leukocytes can alsometabolize2AF into agentsmutagenic
to Salmonella.
Polymorphonuclear leukocytes appear to do the major-
ity of the metabolizing of2AF in this system, although a
small portion ofactivation is seen with mononuclear cells.
This finding suports other data describing the ability of
PMNs to bioactivate many different xenobiotics. Phorbol-
ester-stimulated human and rodent PMNs have been
shown to activate bleomycin (17), procainamide (18),
diethylstilbestrol (19), eugenol (20), BaP-7,8-diol (4,11,13),
and many arylamines (6,7,9,12). Phagocytic cells (neu-
trophils and monocytes) but not lymphocytes contain the
enzyme myeloperoxidase. Previous workers have de-
scribed the ability of peroxidaselike enzymes such as
prostaglandin endoperoxide synthetase (PES), horse-
radish peroxidase (HRP), and myeloperoxidase (MPO) to
activate 2AF. PES can co-metabolize 2AF into a Salmo-
nellamutageninthepresence ofarachidonic acid (14), PES
and HRP can oxidize 2AF (21), and HRP and MPO can
activate 2AF into a DNA binding species (6,7). If
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FIGURE 4. Activation of2-aminofluorene byincr-easing concentr-ations of
mononuclear leukocytes (MNs) (A - A) and polymorphonuclear leuko-
cytes (PMNs) (A -A). To confirm and extend the results shown in
Figure 3, the same procedure was done with higher cell densities. MNs
were incubated at 0.16, 0.34, 0.58, 1.34, 2.12, 3.31 million cells/mL, and
PMNs were incubated at 0.36, 0.52,1.13, 2.09, 3.23, and 4.78 million cells/
mL with 250 p.M 2-aminofluorene.
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myeloperoxidase is activating 2AF in this system, one
wouldpredictresults similarto ours,i.e.,thatPMNswould
showthe greatest activationbecause most are neutrophils
and the MNs would show a small amount of activation
because most are lymphocytes and only some are mono-
cytes. In a study of the oxidation of procainamide, MNs
oxidizedthechemical10timeslessthanthePMNs(18),and
inanotherstudyontheformationofDNAadductsbyPMNs
and MNs, the MNs showed 5 times less adduct formation
than the PMNs (10). These results are consistent with the
lower level ofactivation seen by the MNs in our system.
Initially, we supposed our system would reflect the
uptake of2AF bythe leukocytes and the release ofmuta-
genic metabolites into the surrounding media,whichwere
detected with the Salmonella assay. Actually, it is unclear
whether metabolism of 2AF is occurring inside the cells
with the metabolites being released orwhether the leuko-
cytesarereleasingagentsthatmetabolizethe2AFoutside
of the cells because in either case one would detect the
metabolites inthesurroundingmedia.Preliminaryexperi-
ments suggest the metabolism is occurring within cells
(i.e., the cells need to be present during the incubation
periodbecause "conditionedmedia" [mediaincubatedwith
cells for 18 hr] cannot activate 2AF [Isola, unpublished
observations]). Otherinvestigators have detectedmetabo-
lites of 2AF bound to DNA found both outside (10) and
inside (6-8,12) of the activating cell. Although, in these
situations as well, metabolism could occur either outside,
inside, or perhaps both outside and inside the cell (7).
Itis important to note thatthe metabolism of2AF seen
inthissystemisbeingperformedby"unstimulated" leuko-
cytes, whereas the majority ofevidence for 2AF metabo-
lism in the literature comes from "stimulated" leukocytes
only. Corbett and Corbett (7) found human PMNs activate
2AFintoanucleicacidbindingspeciesonlyinthepresence
ofa phorbol ester (which stimulates respiratory burst), in
up to a1-hrincubationperiod. Similarily, Tsuruta etal. (6)
found guineapigPMNs activated 2AFinto aDNAbinding
species only in the presence ofphorbol ester during a 20-
min incubation period. It is likely that the length of the
incubation period (18 hr) in our system contributes to the
detection of2AF metabolites. This phenomenon was also
seen by Gupta et al. (8) who saw maximal production of
2AF DNA adducts formed within mononuclear cell cul-
tures incubated with 2AF for 18 hr. The mechanism of
activation of 2AF by the leukocytes in this system is
unknown. Both the reactive oxygen species produced by
phagocytic cells during the respiratory burst and the
enzymemyeloperoxidasehavebeenimplicatedbyothersin
the activation of2AF (6,7,10,12) and many other xenobio-
tics (4,9,11,13,17-20). Furtherexperimentation isneeded to
determine the mechanism of activation of 2AF in this
system. Interestingly, Twerdok and Trush (22) compared
the response ofresting andphorbol-ester-stimulated bone
marrow neutrophils to myeloperoxidase-dependent and
superoxide-anion-dependent chemiluminescence and
found both responses in stimulated neutrophils but only a
superoxide anion response in resting cells. Superoxide
anion may be involved in the activation of 2AF in this
resting system.
Inaddition,thenatureofthe2AFmetabolitesformedin
this system is currently unknown. It is well documented
that cytochrome P450 enzymes metabolize 2AF into
N-hydroxy-2-aminofluorene (N-OH-2AF),whichisconsid-
ered the ultimate mutagenic metabolite. There are some
reports of human leukocytes activating 2AF to produce
the DNA adduct C8-(N2-aminofluorenyl)-deoxyguano-
sine-3'-5'-diphosphate (C8-dG-2AF), which is the only
metabolite formed from theultimatemutagen N-OH-2AF
(8,10). In contrast, other investigations have revealed that
some enzyme systems metabolize 2AF to DNA binding
species other than that seen by N-OH-2AF (7,12,21). In
addition, both C8-dG-2AF and other 2AF DNA adducts
have been found in vivo (23). Perhaps the metabolites
produced in this system are different from the expected
N-OH-2AF because mutagenesis of the bacteria in our
systemisenhancedbyanextendedpreincubationperiod (3
hr) with the unknown metabolites and incubation of2AF
withratliverS9,whichproduces N-OH-2AF onlyrequires
a 30-min preincubation to be detected as mutations in
Salmonella.Alternatively,this systemcouldbeproducinga
very small amount of N-OH-2AF whose detection is
enhanced by the longer preincubation period.
We and others have hypothesized thatthe accumulation
of PMNs at sites of infection could generate genotoxic
metabolites if the individual is exposed to a promutagen,
andthesemetabolitesmayaffectthesurroundingtissuein
away to initiate or promote tumor formation. The results
presented in this paper further support this hypothesis.
However, more research must be conducted ifthe associa-
tionbetween inflammation and canceris tobe fullyunder-
stood.
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